Atypical chemokine receptor ACKR2 controls branching morphogenesis in the developing mammary gland

Development (Cambridge)

Volumn 144, Issue 1, 2017, Pages 74-82

  Wilson, Gillian J ^a   Hewit, Kay D ^a   Pallas, Kenneth J ^a   Cairney, Claire J ^a   Lee, Kit M ^a   Hansell, Christopher A ^a   Stein, Torsten ^a   Graham, Gerard J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

ACKR2; Branching; Chemokines; Mammary gland; Mouse

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR ACKR2; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; UNCLASSIFIED DRUG; CC CHEMOKINE RECEPTOR 9; CHEMOKINE RECEPTOR CCR;

ANIMAL EXPERIMENT; ARTICLE; BRANCHING MORPHOGENESIS; BREAST DEVELOPMENT; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; INGUINAL LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; ANIMAL; C57BL MOUSE; CELL MOTION; EMBRYOLOGY; GENETICS; KNOCKOUT MOUSE; LYMPH VESSEL; LYMPHANGIOGENESIS; MAMMALIAN EMBRYO; METABOLISM; MORPHOGENESIS; PHYSIOLOGY; STROMA CELL; UDDER;

ANIMALS; CELL MOVEMENT; EMBRYO, MAMMALIAN; FEMALE; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MACROPHAGES; MAMMARY GLANDS, ANIMAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MORPHOGENESIS; RECEPTORS, CCR; RECEPTORS, CHEMOKINE; STROMAL CELLS;

EID: 85008490323     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.139733     Document Type: Article

References (44)

1. Bachelerie, F., Graham, G. J., Locati, M., Mantovani, A., Murphy, P. M., Nibbs, R., Rot, A., Sozzani, S. and Thelen, M. (2014). New nomenclature for atypical chemokine receptors. Nat. Immunol. 15, 207-208.
2. Balkwill, F. (2004). Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
3. Berry, R. and Rodeheffer, M. S. (2013). Characterization of the adipocyte cellular lineage in vivo. Nat. Cell Biol. 15, 302-308.
4. Blackburn, P. E., Simpson, C. V., Nibbs, R. J. B., O’Hara, M., Booth, R., Poulos, J., Isaacs, N. W. and Graham, G. J. (2004). Purification and biochemical characterization of the D6 chemokine receptor. Biochem. J. 379, 263-272.
5. Clarkson, R. W., Wayland, M. T., Lee, J., Freeman, T. and Watson, C. J. (2003). Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res. 6, 1-18.
6. Di Liberto, D., Locati, M., Caccamo, N., Vecchi, A., Meraviglia, S., Salerno, A., Sireci, G., Nebuloni, M., Caceres, N., Cardona, P.-J. et al. (2008). Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection. J. Exp. Med. 205, 2075-2084.
7. Ford, L., Hansell, C. H. and Nibbs, R. B. (2013). Using fluorescent chemokine uptake to detect chemokine receptors by fluorescent activated cell sorting. In Chemokines (ed. A. E. Cardona & E. E. Ubogu), pp. 203-214. New York, USA:Humana Press.
8. Fra, A. M., Locati, M., Otero, K., Sironi, M., Signorelli, P., Massardi, M. L., Gobbi, M., Vecchi, A., Sozzani, S. and Mantovani, A. (2003). Cutting edge: scavenging of inflammatory CC chemokines by the promiscuous putatively silent chemokine receptor D6. J. Immunol. 170, 2279-2282.
9. Fridrichova, I., Smolkova, B., Kajabova, V., Zmetakova, I., Krivulcik, T., Mego, M., Cierna, Z., Karaba, M., Benca, J., Pindak, D. et al. (2015). CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers. Transl. Res. 165, 717-730.
10. Gouon-Evans, V., Rothenberg, M. E. and Pollard, J. W. (2000). Postnatal mammary gland development requires macrophages and eosinophils. Development 127, 2269-2282.
11. Griffith, J. W., Sokol, C. L. and Luster, A. D. (2014). Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32, 659-702.
12. Hansell, C. A. H., Schiering, C., Kinstrie, R., Ford, L., Bordon, Y., McInnes, I. B., Goodyear, C. S. and Nibbs, R. J. B. (2011). Universal expression and dual function of the atypical chemokine receptor D6 on innate-like B cells in mice. Blood 117, 5413-5424.
13. Hens, J. R. and Wysolmerski, J. J. (2005). Key stages of mammary gland development: molecular mechanisms involved in the formation of the embryonic mammary gland. Breast Cancer Res. 7, 220-224.
14. Howlin, J., McBryan, J. and Martin, F. (2006). Pubertal mammary gland development: insights from mouse models. J. Mammary Gland Biol. Neoplasia 11, 283-297.
15. Hromas, R., Broxmeyer, H. E., Kim, C., Nakshatri, H., Christopherson, K., II, Azam, M. and Hou, Y.-H. (1999). Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem. Biophys. Res. Commun. 255, 703-706.
16. Ingman, W. V., Wyckoff, J., Gouon-Evans, V., Condeelis, J. and Pollard, J. W. (2006). Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev. Dyn. 235, 3222-3229.
17. Jamieson, T., Cook, D. N., Nibbs, R. J. B., Rot, A., Nixon, C., McLean, P., Alcami, A., Lira, S. A., Wiekowski, M. and Graham, G. J. (2005). The chemokine receptor D6 limits the inflammatory response in vivo. Nat. Immunol. 6, 403-411.
18. Kayo, H., Kiga, K., Fukuda-Yuzawa, Y., Hedlund, S., Murakami, K., De La Rosa-Velazquez, I. A., Kimura, T., Shimoda, K., Tanabe, M. and Fukao, T. (2014). miR-212 and miR-132 are dispensable for mouse mammary gland development. Nat. Genet. 46, 802-804.
19. Lee, K. M., Danuser, R., Stein, J. V., Graham, D., Nibbs, R. J. B. and Graham, G. J. (2014). The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density. EMBO J. 33, 2564-2580.
20. Lilla, J. N. and Werb, Z. (2010). Mast cells contribute to the stromal microenvironment in mammary gland branching morphogenesis. Dev. Biol. 337, 124-133.
21. Lin, E. Y., Nguyen, A. V., Russell, R. G. and Pollard, J. W. (2001). Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193, 727-740.
22. Macias, H. and Hinck, L. (2012). Mammary gland development. Wiley Interdiscipl. Rev. Dev. Biol. 1, 533-557.
23. Martinez de la Torre, Y., Buracchi, C., Borroni, E. M., Dupor, J., Bonecchi, R., Nebuloni, M., Pasqualini, F., Doni, A., Lauri, E., Agostinis, C. et al. (2007). Protection against inflammation- and autoantibody-caused fetal loss by the chemokine decoy receptor D6. Proc. Natl. Acad. Sci. USA 104, 2319-2324.
24. McKimmie, C. S., Fraser, A. R., Hansell, C., Gutiérrez, L., Philipsen, S., Connell, L., Rot, A., Kurowska-Stolarska, M., Carreno, P., Pruenster, M. et al. (2008). Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1. J. Immunol. 181, 8170-8181.
25. Morteau, O., Gerard, C., Lu, B., Ghiran, S., Rits, M., Fujiwara, Y., Law, Y., Distelhorst, K., Nielsen, E. M., Hill, E. D. et al. (2008). An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J. Immunol. 181, 6309-6315.
26. Nibbs, R. J. B. and Graham, G. J. (2013). Immune regulation by atypical chemokine receptors. Nat. Rev. Immunol. 13, 815-829.
27. Nibbs, R. J. B., Kriehuber, E., Ponath, P. D., Parent, D., Qin, S., Campbell, J. D. M., Henderson, A., Kerjaschki, D., Maurer, D., Graham, G. J. et al. (2001). The β-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. Am. J. Pathol. 158, 867-877.
28. Nibbs, R. J. B., Gilchrist, D. S., King, V., Ferra, A., Forrow, S., Hunter, K. D. and Graham, G. J. (2007). The atypical chemokine receptor D6 suppresses the development of chemically induced skin tumors. J. Clin. Invest. 117, 1884-1892.
29. Nomiyama, H., Osada, N. and Yoshie, O. (2011). A family tree of vertebrate chemokine receptors for a unified nomenclature. Dev. Comp. Immunol. 35, 705-715.
30. Olijnyk, D., Ibrahim, A. M., Ferrier, R. K., Tsuda, T., Chu, M.-L., Gusterson, B. A., Stein, T. and Morris, J. S. (2014). Fibulin-2 is involved in early extracellular matrix development of the outgrowing mouse mammary epithelium. Cell. Mol. Life Sci. 71, 3811-3828.
31. Parmar, H. and Cunha, G. R. (2004). Epithelial-stromal interactions in the mouse and human mammary gland in vivo. Endocr. Related Cancer 11, 437-458.
32. Pollard, J.W. and Hennighausen, L. (1994). Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc. Natl. Acad. Sci. USA 91, 9312-9316.
33. Reed, J. R. and Schwertfeger, K. L. (2010). Immune cell location and function during post-natal mammary gland development. J. Mammary Gland Biol. Neoplasia 15, 329-339.
34. Salazar, N., Muñoz, D., Kallifatidis, G., Singh, R. K., Jordà, M. and Lokeshwar, B. L. (2014). The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation. Mol. Cancer 13, 1-13.
35. Schneider, C. A., Rasband,W. S. and Eliceiri, K.W. (2012). NIH Image to ImageJ:25 years of image analysis. Nat. Methods 9, 671-675.
36. Singh, M. D., King, V., Baldwin, H., Burden, D., Thorrat, A., Holmes, S., McInnes, I. B., Nicoll, R., Shams, K., Pallas, K. et al. (2012). Elevated expression of the chemokine-scavenging receptor D6 is associated with impaired lesion development in psoriasis. Am. J. Pathol. 181, 1158-1164.
37. Singhal, P. K., Sassi, S., Lan, L., Au, P., Halvorsen, S. C., Fukumura, D., Jain, R. K. and Seed, B. (2016). Mouse embryonic fibroblasts exhibit extensive developmental and phenotypic diversity. Proc. Natl. Acad. Sci. USA 113, 122-127.
38. Stein, T., Morris, J. S., Davies, C. R.,Weber-Hall, S. J., Duffy, M.-A., Heath, V. J., Bell, A. K., Ferrier, R. K., Sandilands, G. P. and Gusterson, B. A. (2004). Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res. 6, R75-R91.
39. Topper, Y. J. and Freeman, C. S. (1980). Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 60, 1049-1106.
40. Weber, M., Blair, E., Simpson, C. V., O’Hara, M., Blackburn, P. E., Rot, A., Graham, G. J. and Nibbs, R. J. (2004). The chemokine receptor D6 constitutively traffics to and from the cell surface to internalize and degrade chemokines. Mol. Biol. Cell 15, 2492-2508.
41. White, G. E., Iqbal, A. J. and Greaves, D. R. (2013). CC chemokine receptors and chronic inflammation-therapeutic opportunities and pharmacological challenges. Pharmacol. Rev. 65, 47-89.
42. Wiseman, B. S. and Werb, Z. (2002). Stromal effects on mammary gland development and breast cancer. Science 296, 1046-1049.
43. Wynn, T. A., Chawla, A. and Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496, 445-455.
44. Zlotnik, A. and Yoshie, O. (2000). Chemokines: a new classification system and their role in immunity. Immunity 12, 121-127.